InvestorsHub Logo
Followers 62
Posts 7549
Boards Moderated 1
Alias Born 01/02/2003

Re: Whalatane post# 395357

Saturday, 12/10/2022 2:26:34 PM

Saturday, December 10, 2022 2:26:34 PM

Post# of 425926
KIWI...QUOTE..."he(JL) decided not to take the risk of a negative ruling even tho he thought chances of a -ve ruling were low ...and then sold the rest after the Judge Du ruling.

J.L. had a daughter, who was a lawyer, who understood the probability that the high triglyceride patent loss would result in generic skinny label infringement on Amarin's Vascepa CVD patent label...which scenario has unfortunately come to pass...and J.L. took her advice and sold.

J.T., then the CEO of Amarin, failed to take the necessary steps to defend Vascepa and was fired by Eckman, who also failed help with any plan to support Amarin ...resulting in Amarin falling to the position it is presently in...The rational for my holding my shares is because I feel that that Denner will soon take the necessary steps to restore either Vascepa (or MND2119) to its deserved status in the U.S. and the ROW as a companion of statins in the prevention and treatment of CVD.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News